California Pharmacy Law Exam

✅ Quality Assurance and Improvement

What this topic covers

Subpart 3B (Perform Quality Assurance/Improvement) of the Content Outline effective June 1, 2022: quality assurance programs, medication errors, compounding complaints, adverse event reporting, continuing education and the competence of pharmacy personnel. These are original practice notes, not documents of the California State Board of Pharmacy or PSI, based on law in force on January 1, 2027; time limits, thresholds and quantities can change with each year's legislation. Nothing here is medical advice.

Quality assurance program

Medication errors

Self-assessment and compounding quality

Outcomes and adverse events

Continuing education

Personnel competence

Take the free test · full question bank and mock exams with a subscription

Sample questions (5)

1. Which of the following must every pharmacy establish under Business and Professions Code section 4125?

  1. A drug utilization review committee
  2. A quality assurance program for errors
  3. An external audit of pharmacy safety
  4. A peer review panel of pharmacists

Business and Professions Code section 4125(a) requires every pharmacy to “establish a quality assurance program” that documents medication errors attributable, in whole or in part, to the pharmacy or its personnel. The section names no drug utilization review committee and no external audit. A peer review panel is not required either: subdivision (b) only gives the program's records the status of peer review documents.

2. A pharmacist at Sierra Valley Pharmacy discovers a medication error. Within what period must the pharmacy commence an investigation of it under 16 CCR section 1711(d)?

  1. Within 1 business day of discovery
  2. Within 2 business days of discovery
  3. Within 3 business days of discovery
  4. Within 5 business days of discovery

As of January 1, 2027, 16 CCR section 1711(d) requires the investigation to “commence as soon as is reasonably possible, but no later than 2 business days” from the date the medication error is discovered. One business day is shorter than the outer limit the regulation sets, and three or five business days go past that limit.

3. After a dispensing error, the pharmacist-in-charge of Juniper Flats Pharmacy completes the quality assurance review and creates its record. Under 16 CCR section 1711(f), for how long must that record remain immediately retrievable in the pharmacy?

  1. For at least 1 year from its creation
  2. For at least 2 years from its creation
  3. For at least 3 years from its creation
  4. For at least 5 years from its creation

As of January 1, 2027, the record described in 16 CCR section 1711(e) must be “immediately retrievable in the pharmacy for at least one year from the date the record was created” under section 1711(f). A three-year period governs other documents, such as the self-assessment that 16 CCR section 1715(d) keeps on file, while two and five years are periods that neither section sets for these records.

4. When must the pharmacist-in-charge complete the routine self-assessment of a pharmacy under 16 CCR section 1715(a)?

  1. Before Jan. 1 of each odd-numbered year
  2. Before July 1 of each calendar year
  3. Before July 1 of each even-numbered year
  4. Before July 1 of each odd-numbered year

As of January 1, 2027, 16 CCR section 1715(a) provides that the assessment “shall be performed before July 1 of every odd-numbered year”. The cycle is every two years, not annual, and it falls in odd-numbered years, not even-numbered ones. January 1 is not the deadline in the text.

5. A pharmacist-in-charge completes the pharmacy's self-assessment on March 2, 2027. How long must the completed self-assessment be kept on file in the pharmacy under 16 CCR section 1715(d)?

  1. 1 year after it is performed
  2. 2 years after it is performed
  3. 3 years after it is performed
  4. 5 years after it is performed

As of January 1, 2027, 16 CCR section 1715(d) says each self-assessment is “kept on file in the pharmacy for three years after it is performed”, and the signed original must be readily available to the Board during an inspection. One year is the retrievability period for quality assurance review records in 16 CCR section 1711(f). Two and five years appear in neither section.

Start free

California Pharmacy Law Exam · Topics · Exam guide · Sample questions